Kratom: History, Science and Therapeutic Potential is the first book to address the unregulated, widespread availability of kratom, with its weak opioid and stimulant effects, coupled with limited awareness of it by healthcare professionals. Kratom has great therapeutic utility and medicinal potential, but more study, caution, and possible regulation is needed. It discusses geographical sourcing, historical uses, current worldwide uses, and potential for treatment of other medical conditions. Most exciting for healthcare professionals will be the implications of this substance's potential for…mehr
Kratom: History, Science and Therapeutic Potential is the first book to address the unregulated, widespread availability of kratom, with its weak opioid and stimulant effects, coupled with limited awareness of it by healthcare professionals. Kratom has great therapeutic utility and medicinal potential, but more study, caution, and possible regulation is needed. It discusses geographical sourcing, historical uses, current worldwide uses, and potential for treatment of other medical conditions. Most exciting for healthcare professionals will be the implications of this substance's potential for treatment of diseases like depression, ADHD, PTSD, and substance-use disorder, particularly opioid use disorder (OUD). Moreover, kratom and its active alkaloid mitragynine are getting remarkable attention at federal and local governments as more than eight million Americans consume this product annually. Yet, the paucity of information for researchers and clinicians is troublesome.
Section 1: Background 1. Botany, geographical distribution, and phytochemistry of Mitragyna speciosa (Korth.) and related species Satya Swathi Nadakuduti, Mengzi Zhang, Larissa C. Laforest and Brian Pearson 2. The scientific evolution of kratom: a historical overview Thiruventhan Karunakaran, Yathindra Marimuthu, Balasingam Vicknasingam and Marek C. Chawarski 3. Recent patterns and reasons for use Marc T. Swogger, Kirsten E. Smith, Tianna Torrice and Oliver Grundmann Section 2: Basic science 4. Chemistry and metabolites: ADME Manoj Gundeti, Christopher R. Mccurdy and Abhisheak Sharma Section 3: Current therapeutic uses 5. Kratom-related physical dependence and addiction Kirsten E. Smith, Darshan Singh and Oliver Grundmann 6. Current therapeutic uses Norsyifa Harun, Siti Rafidah Yusof and Farah Wahida Suhaimi Section 4: Pharmaceutical drug development of kratom-derived products 7. Regulation and policy regarding kratom-derived dietary supplements and direct-to-consumer sales Robert Durkin, Oliver Grundmann and Kirsten E. Smith 8. Patentability and exclusivity of kratom based natural products Robert Paradiso Section 5: Concerns 9. Kratom drug-drug (and other) interactions Robert B. Raffa and Jeanette Mathews 10. Susceptible populations Robert B. Raffa and Jeanette Mathews Section 6: Commentaries/Perspectives 11. Kratom purity and quality control issues: an in-depth analysis Frank Breve 12. Kratom entrepreneurship exploiting the commercial potential of kratom and its active alkaloids Chad E. Beyer 13. Equity investment into kratom, mitragynine, and related products Zachariah Mcintosh-Pearce 14. Medical marijuana as a template for understanding kratom Soren Shade
Section 1: Background 1. Botany, geographical distribution, and phytochemistry of Mitragyna speciosa (Korth.) and related species Satya Swathi Nadakuduti, Mengzi Zhang, Larissa C. Laforest and Brian Pearson 2. The scientific evolution of kratom: a historical overview Thiruventhan Karunakaran, Yathindra Marimuthu, Balasingam Vicknasingam and Marek C. Chawarski 3. Recent patterns and reasons for use Marc T. Swogger, Kirsten E. Smith, Tianna Torrice and Oliver Grundmann Section 2: Basic science 4. Chemistry and metabolites: ADME Manoj Gundeti, Christopher R. Mccurdy and Abhisheak Sharma Section 3: Current therapeutic uses 5. Kratom-related physical dependence and addiction Kirsten E. Smith, Darshan Singh and Oliver Grundmann 6. Current therapeutic uses Norsyifa Harun, Siti Rafidah Yusof and Farah Wahida Suhaimi Section 4: Pharmaceutical drug development of kratom-derived products 7. Regulation and policy regarding kratom-derived dietary supplements and direct-to-consumer sales Robert Durkin, Oliver Grundmann and Kirsten E. Smith 8. Patentability and exclusivity of kratom based natural products Robert Paradiso Section 5: Concerns 9. Kratom drug-drug (and other) interactions Robert B. Raffa and Jeanette Mathews 10. Susceptible populations Robert B. Raffa and Jeanette Mathews Section 6: Commentaries/Perspectives 11. Kratom purity and quality control issues: an in-depth analysis Frank Breve 12. Kratom entrepreneurship exploiting the commercial potential of kratom and its active alkaloids Chad E. Beyer 13. Equity investment into kratom, mitragynine, and related products Zachariah Mcintosh-Pearce 14. Medical marijuana as a template for understanding kratom Soren Shade
Es gelten unsere Allgemeinen Geschäftsbedingungen: www.buecher.de/agb
Impressum
www.buecher.de ist ein Internetauftritt der buecher.de internetstores GmbH
Geschäftsführung: Monica Sawhney | Roland Kölbl | Günter Hilger
Sitz der Gesellschaft: Batheyer Straße 115 - 117, 58099 Hagen
Postanschrift: Bürgermeister-Wegele-Str. 12, 86167 Augsburg
Amtsgericht Hagen HRB 13257
Steuernummer: 321/5800/1497
USt-IdNr: DE450055826